• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺素 F2α 类似物氟前列醇可减轻结缔组织生长因子对人眼小梁细胞的纤维增生作用。

The prostaglandin f2α analog fluprostenol attenuates the fibrotic effects of connective tissue growth factor on human trabecular meshwork cells.

机构信息

Institute of Human Anatomy and Embryology, University of Regensburg , Regensburg, Germany .

出版信息

J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):237-45. doi: 10.1089/jop.2013.0205. Epub 2014 Feb 27.

DOI:10.1089/jop.2013.0205
PMID:24576038
Abstract

UNLABELLED

Abstract Purpose: The trabecular meshwork (TM) outflow pathways of the aqueous humor show an increase in extracellular matrix in patients with primary open-angle glaucoma (POAG). The increase in TM extracellular matrix appears to be caused by transforming growth factor-β signaling and its downstream mediator connective-tissue growth factor (CTGF). Here we studied whether treatment with the prostaglandin F2α analog fluprostenol modulates the CTGF-mediated increase of the TM extracellular matrix.

METHODS

Human TM cells from 3 different donors were treated with CTGF (50 ng/mL) and/or fluprostenol (10(-6) M and 10(-7) M) and were analyzed by real-time reverse transcription polymerase chain reaction and Western blotting. Cell supernatants of the treated cells were analyzed by zymography.

RESULTS

Treatment with CTGF induced the expression and synthesis of CTGF, fibronectin, collagen type IV and VI, while treatment with fluprostenol alone had no effects. The effects of CTGF were blocked by 1-h pretreatment with fluprostenol in a dose-dependent manner. Treatment with fluprostenol or combined fluprostenol/CTGF induced the activity of matrix metalloproteinase 2 (MMP2) in TM cells, whereas treatment with CTGF alone had no effects on MMP2 activity.

CONCLUSIONS

Fluprostenol blocks the fibrotic effects of CTGF on human TM cells and increases the activity of MMP2. Both effects have the distinct potential to attenuate a CTGF-mediated increase in TM extracellular matrix in patients with POAG and any effects on TM outflow resistance that may result from that.

摘要

未加标签

摘要目的:原发性开角型青光眼(POAG)患者的小梁网(TM)房水流出途径的细胞外基质增加。TM 细胞外基质的增加似乎是由转化生长因子-β信号及其下游介质结缔组织生长因子(CTGF)引起的。在这里,我们研究了前列腺素 F2α 类似物氟前列醇的治疗是否调节 CTGF 介导的 TM 细胞外基质增加。方法:用 CTGF(50ng/mL)和/或氟前列醇(10(-6)M 和 10(-7)M)处理来自 3 个不同供体的人 TM 细胞,并通过实时逆转录聚合酶链反应和 Western blot 进行分析。用明胶酶谱法分析处理过的细胞的细胞上清液。结果:CTGF 处理诱导 CTGF、纤连蛋白、IV 型和 VI 型胶原的表达和合成,而单独用氟前列醇处理没有影响。CTGF 的作用被氟前列醇以剂量依赖的方式预处理 1 小时所阻断。氟前列醇或联合氟前列醇/CTGF 处理诱导 TM 细胞中基质金属蛋白酶 2(MMP2)的活性,而单独用 CTGF 处理对 MMP2 活性没有影响。结论:氟前列醇阻断 CTGF 对人 TM 细胞的纤维化作用,并增加 MMP2 的活性。这两种作用都有可能减弱 POAG 患者 CTGF 介导的 TM 细胞外基质增加,并可能由此产生对 TM 流出阻力的任何影响。

相似文献

1
The prostaglandin f2α analog fluprostenol attenuates the fibrotic effects of connective tissue growth factor on human trabecular meshwork cells.前列腺素 F2α 类似物氟前列醇可减轻结缔组织生长因子对人眼小梁细胞的纤维增生作用。
J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):237-45. doi: 10.1089/jop.2013.0205. Epub 2014 Feb 27.
2
Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells.结缔组织生长因子诱导人小梁网细胞中的细胞外基质沉积。
Exp Eye Res. 2009 Jun;88(6):1065-75. doi: 10.1016/j.exer.2009.01.008. Epub 2009 Feb 7.
3
Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.骨形态发生蛋白-7是人类小梁网细胞中转化生长因子-β2的拮抗剂。
Invest Ophthalmol Vis Sci. 2007 Feb;48(2):715-26. doi: 10.1167/iovs.06-0226.
4
Connective tissue growth factor is increased in pseudoexfoliation glaucoma.结缔组织生长因子在假性剥脱性青光眼患者中增加。
Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3660-6. doi: 10.1167/iovs.10-5209.
5
Anti-connective tissue growth factor antibody treatment reduces extracellular matrix production in trabecular meshwork and lamina cribrosa cells.抗结缔组织生长因子抗体治疗可减少小梁网和筛板细胞细胞外基质的产生。
Invest Ophthalmol Vis Sci. 2013 Dec 2;54(13):7836-48. doi: 10.1167/iovs.13-12494.
6
The regulation of connective tissue growth factor expression influences the viability of human trabecular meshwork cells.结缔组织生长因子表达的调控影响人小梁网细胞的活力。
J Cell Mol Med. 2015 May;19(5):1010-20. doi: 10.1111/jcmm.12492. Epub 2015 Feb 20.
7
Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork.结缔组织生长因子通过改变小梁网的肌动蛋白细胞骨架引起青光眼。
Am J Pathol. 2012 Jun;180(6):2386-403. doi: 10.1016/j.ajpath.2012.02.030. Epub 2012 Apr 26.
8
Adenovirus conducted connective tissue growth factor on extracellular matrix in trabecular meshwork and its role on aqueous humor outflow facility.腺病毒对小梁网细胞外基质中结缔组织生长因子的作用及其对房水流出通道的影响。
Mol Biol Rep. 2013 Nov;40(11):6091-6. doi: 10.1007/s11033-013-2720-2. Epub 2013 Sep 20.
9
Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells.前列腺素FP和EP2受体的激活对成人原代人小梁网细胞模型中肌成纤维细胞转化的调节作用不同。
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1816-25. doi: 10.1167/iovs.15-17693.
10
Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.转化生长因子-β2 通过经典 Smad 信号通路调节人眼小梁细胞组织转谷氨酰胺酶的表达。
Exp Eye Res. 2011 Oct;93(4):442-51. doi: 10.1016/j.exer.2011.06.011. Epub 2011 Jun 24.

引用本文的文献

1
Aqueous Humor Concentrations of Travoprost Free Acid and Residual Drug in Explanted Implants from Patients Administered a Travoprost Intracameral Implant.接受曲伏前列素前房内植入的患者摘除的植入物中曲伏前列素游离酸和残留药物的房水浓度
Ophthalmol Ther. 2025 May;14(5):989-1003. doi: 10.1007/s40123-025-01130-1. Epub 2025 Mar 24.
2
Sigma-1 Receptor Activation Is Protective against TGFβ2-Induced Extracellular Matrix Changes in Human Trabecular Meshwork Cells.西格玛-1受体激活对转化生长因子β2诱导的人小梁网细胞外基质变化具有保护作用。
Life (Basel). 2023 Jul 19;13(7):1581. doi: 10.3390/life13071581.
3
Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork.
青光眼:小梁网的新型抗纤维化治疗方法。
Eur J Pharmacol. 2023 Sep 5;954:175882. doi: 10.1016/j.ejphar.2023.175882. Epub 2023 Jun 28.
4
Remodeling of the Lamina Cribrosa: Mechanisms and Potential Therapeutic Approaches for Glaucoma.筛板重塑:青光眼的潜在治疗方法及机制。
Int J Mol Sci. 2022 Jul 22;23(15):8068. doi: 10.3390/ijms23158068.
5
Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells.EP2激动剂奥米地帕异丙酯与前列腺素F2α对转化生长因子-β2调节的人小梁网(HTM)细胞的药物诱导效力比较。
J Clin Med. 2022 Mar 16;11(6):1652. doi: 10.3390/jcm11061652.
6
Screening of the Drug-Induced Effects of Prostaglandin EP2 and FP Agonists on 3D Cultures of Dexamethasone-Treated Human Trabecular Meshwork Cells.前列腺素EP2和FP激动剂对经地塞米松处理的人小梁网细胞三维培养物的药物诱导效应筛选
Biomedicines. 2021 Jul 31;9(8):930. doi: 10.3390/biomedicines9080930.
7
Endogenous ocular lipids as potential modulators of intraocular pressure.内源性眼内脂质作为眼内压的潜在调节剂。
J Cell Mol Med. 2020 Apr;24(7):3856-3900. doi: 10.1111/jcmm.14975. Epub 2020 Feb 23.
8
Matricellular proteins in the trabecular meshwork: review and update.小梁网中的基质细胞蛋白:综述与更新
J Ocul Pharmacol Ther. 2014 Aug;30(6):447-63. doi: 10.1089/jop.2014.0013. Epub 2014 Jun 5.